Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-09

FDA Approved: NASACORT ALLERGY 24HR — Supplemental Application (Chattem, Inc.)

View source ↗

Summary

FDA approved a supplemental application for NASACORT ALLERGY 24HR (triamcinolone acetonide) from Chattem, Inc. This action represents a supplemental approval to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NASACORT ALLERGY 24HR (TRIAMCINOLONE ACETONIDE)

Snippet

SUPPL AP for NASACORT ALLERGY 24HR (TRIAMCINOLONE ACETONIDE)